Related Experiment Video
Updated: Feb 26, 2026

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
Published on: May 20, 2020
Crystal Structure of a Human K-Ras G12D Mutant in Complex with GDP and the Cyclic Inhibitory Peptide KRpep-2d
Satoshi Sogabe1, Yusuke Kamada1, Masanori Miwa1
1Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa 251-8555, Japan.
Abstract:
The Ras proteins play roles in cell differentiation, proliferation, and survival. Aberrant signaling through Ras-mediated pathways in tumor cells occurs as a result of several types of mutational damage, which most frequently affects the amino acids G12, G13, and Q61. Recently, KRpep-2d was identified as a K-Ras(G12D) selective inhibitory peptide against the G12D mutant of K-Ras, which is a key member of the Ras protein family and an attractive cancer therapeutic target. In this study, the crystal structure of the human K-Ras(G12D) mutant was determined in complex with GDP and KRpep-2d at 1.25 Å resolution. This structure revealed that the peptide binds near Switch II and allosterically blocks protein-protein interactions with the guanine nucleotide exchange factor. This discovery of a unique binding pocket provides valuable information that will facilitate the design of direct Ras inhibitors.
Insights
KRpep-2d is a peptide that inhibits the K-Ras(G12D) cancer target. Its crystal structure reveals a unique binding pocket, aiding the development of direct Ras inhibitors for cancer therapy.
Area of Science:
- Oncology
- Molecular Biology
- Structural Biology
Background:
- Ras proteins regulate crucial cell functions like differentiation and survival.
- Mutations in Ras proteins, particularly at G12, G13, and Q61, drive tumor cell signaling.
- K-Ras(G12D) is a common oncogenic mutation and a target for cancer therapeutics.
Purpose of the Study:
- To determine the crystal structure of human K-Ras(G12D) in complex with GDP and the inhibitory peptide KRpep-2d.
- To elucidate the binding mechanism of KRpep-2d to K-Ras(G12D).
- To identify a unique binding pocket for facilitating the design of novel Ras inhibitors.
Main Methods:
- X-ray crystallography
- Protein-ligand complex structure determination
- Analysis of protein-protein interaction interfaces
Main Results:
- The crystal structure of human K-Ras(G12D)-GDP-KRpep-2d complex was determined at 1.25 Å resolution.
- KRpep-2d binds to a site near the Switch II region of K-Ras(G12D).
- The peptide binding allosterically inhibits interactions with guanine nucleotide exchange factors.
Conclusions:
- The determined structure reveals a novel binding pocket for KRpep-2d.
- This structural information is valuable for designing direct inhibitors targeting Ras proteins.
- The findings support the development of targeted cancer therapies against Ras-mutated tumors.
More Related Videos
07:08Fully Processed Recombinant KRAS4b: Isolating and Characterizing the Farnesylated and Methylated Protein
Published on: January 16, 2020
09:19Strategic Screening and Characterization of the Visual GPCR-mini-G Protein Signaling Complex for Successful Crystallization
Published on: March 16, 2020
Related Concept Videos
The Ras Gene
Ras is a...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Rab Proteins
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
Activation and Inactivation of G Proteins
GTPases and their Regulation
Large G-proteins,...
GPCR Desensitization